Recent Finacing
Recent Raise
Nuage Therapeutics is a biotech company developing a novel drug targeting the most common subtype of small-cell lung cancer (SCLC-A).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Nuage Therapeutics.
